Glenmede Trust CO Na Natera, Inc. Transaction History

Glenmede Trust CO Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $1.23 Million - $1.72 Million	-14,332 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$91.47 - $124.36 $19,666 - $26,737	215 Added 1.52%	14,332 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $346,365 - $580,601	5,196 Added 58.24%	14,117 $1.4 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $159,467 - $252,528	3,475 Added 63.81%	8,921 $644,000
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $30,762 - $58,186	1,167 Added 27.27%	5,446 $271,000
Q4 2019 Feb 12, 2020	BUY	$32.1 - $40.4 $6,227 - $7,837	194 Added 4.75%	4,279 $144,000
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $2,030 - $2,791	80 Added 2.0%	4,085 $133,000
Q2 2019 Aug 13, 2019	BUY	$17.75 - $27.58 $71,088 - $110,457	4,005 New	4,005 $110,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.